Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mycobacterium tuberculosis complex drug resistance in Italy.
Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Scarparo C, Cirillo D, Gori A, Cassone A, Piersimoni C. Migliori GB, et al. Among authors: centis r. Emerg Infect Dis. 2004 Apr;10(4):752-3. doi: 10.3201/eid1004.030667. Emerg Infect Dis. 2004. PMID: 15211998 Free PMC article. No abstract available.
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Migliori GB, et al. Among authors: centis r. Clin Infect Dis. 2008 Mar 15;46(6):958-9. doi: 10.1086/528875. Clin Infect Dis. 2008. PMID: 18288911 Free article. No abstract available.
Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group. Eker B, et al. Among authors: centis r. Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729. Emerg Infect Dis. 2008. PMID: 18976552 Free PMC article.
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.
Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Guenther G, Hoffmann H, Cirillo DM, Toungossova O, Kliiman K, De Lorenzo S, Spanevello A, Lange C; Tuberculosis Network European Trialsgroup. Migliori GB, et al. Among authors: centis r. Clin Infect Dis. 2009 Jul 15;49(2):315-6; author reply 317. doi: 10.1086/600060. Clin Infect Dis. 2009. PMID: 19538069 No abstract available.
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. Among authors: centis r. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.
Drug-resistant tuberculosis: past, present, future.
Chiang CY, Centis R, Migliori GB. Chiang CY, et al. Among authors: centis r. Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Respirology. 2010. PMID: 20337989 Review.
249 results